Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sonenshine Fulford Group is a cross-border healthcare and life sciences M&A and corporate finance advisory group formed through a co-advisory relationship between Sonenshine Partners in New York and The Fulford Group in London. The group focuses primarily on healthcare, life sciences, medtech, medical devices, pharma, and related cross-border transactions rather than developing therapeutic products of its own. It appears to function as the London-facing and healthcare-specialized arm of the broader Sonenshine Partners network, combining U.S. and U.K. advisory capabilities. Publicly available materials indicate the group has advised on fundraising and strategic transactions for healthcare companies, including Hemanext. For biotech analysts, this is best understood as a specialized boutique investment banking/advisory entity serving life sciences and healthcare clients, not an operating drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sonenshine Fulford Group.